Fujifilm Medical Systems USA yesterday announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Aspire HD flat-panel, full-field digital mammography (FFDM) system. The clearance enables the company to offer mammography systems using flat-panel digital radiography and computed radiography approaches alike.
Aspire HD has a proprietary detector that utilizes dual-layer amorphous selenium (a-Se) and Fuji's direct optical switching (DOS) technology. The latter combines with Fuji’s 50-µm resolution to afford enhanced visualization, according to the compay.
Meanwhile, the DOS technology eliminates the need for the thin-film transistors (TFTs) commonly found in currently available flat-panel FFDM systems. The new technology enables a “direct image transfer” process that produces less noise, according to the company.
To read the press release, click here: http://www.prnewswire.com/news-releases/fujifilms-aspire-hd-receives-fda...